← Back to Search

Surgery vs Hair Removal for Pilonidal Disease

N/A
Recruiting
Led By Bill Chiu, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients over the age of 8 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This trial is testing whether surgery is needed to remove pilonidal disease after symptoms have resolved when the patient follows a regular hair removal regimen.

Who is the study for?
This trial is for patients at Stanford Healthcare over the age of 8 with pilonidal disease, who can read and understand English or Spanish. It's not suitable for those with intellectual disabilities that prevent them from understanding or responding to questionnaires.Check my eligibility
What is being tested?
The study compares two approaches: surgical removal of the affected area versus following a regular hair removal regimen, like laser epilation, after initial symptoms are resolved to see if surgery can be avoided.See study design
What are the potential side effects?
Surgical excision may lead to pain, infection, scarring, and longer recovery time. Regular epilation could cause skin irritation, discomfort during treatment sessions, and potential temporary redness or swelling.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 8 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with recurrent symptoms of pilonidal disease
Secondary outcome measures
Effect on parent's daily activities
Number of participants requiring additional surgical intervention
Number of participants requiring antibiotic treatment
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Regular epilation regimen onlyActive Control1 Intervention
Group II: Regular epilation regimen with surgical excisionActive Control2 Interventions

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,378 Previous Clinical Trials
17,332,959 Total Patients Enrolled
Bill Chiu, MDPrincipal InvestigatorStanford University

Media Library

Surgical excision Clinical Trial Eligibility Overview. Trial Name: NCT05439291 — N/A
Pilonidal Disease Research Study Groups: Regular epilation regimen only, Regular epilation regimen with surgical excision
Pilonidal Disease Clinical Trial 2023: Surgical excision Highlights & Side Effects. Trial Name: NCT05439291 — N/A
Surgical excision 2023 Treatment Timeline for Medical Study. Trial Name: NCT05439291 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any availability openings for participants in this trial?

"Evidently, this clinical trial is not accepting candidates; the listing on clinicaltrials.gov was most recently modified on June 27th 2022. Fortunately, there are 4 other medical trials currently recruiting patients at this time."

Answered by AI
~249 spots leftby Jan 2027